A new test promising to revolutionise the way lung cancer is diagnosed has been rolled out in Wales. The innovative biopsy blood test aims to improve cancer treatment and could help more people in Wales.
Lung cancer is the fourth most common cancer and is the leading cause of cancer deaths in Wales. The new non-invasive liquid biopsy (blood sample) can be offered at an earlier stage in the cancer path way and will help speed up treatments, the Welsh Government has announced.
Made possible through the All-Wales Medical Genomics Service (AWMGS), Illumina technology, Life Sciences Hub Wales, and investment from multiple partner organisations, the new use of the blood test can detect multiple cancer markers without needing an invasive tissue biopsy.
